Skip to main content

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of TAK-861 for the treatment of narcolepsy with cataplexy (Narcolepsy Type 1)

Open
  • Protocol code: TAK-861-3001
  • EudraCT code: 2023-508465-32
  • Research group: Pneumology
  • Service: Neurophysiology
  • Principal investigator:  Romero Santo-Tomas, Odile
  • Pathology: Malalties del sistema respiratori
  • Phase: Fase III